Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure

Postdischarge pharmaceutical care allows for reducing the number of new admissions in patients with heart failure, the total days of hospital stay, and improves treatment compliance without increasing the costs of care.